Canada markets closed

Evofem Biosciences, Inc. (EVFM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4051-0.6949 (-63.17%)
At close: 04:00PM EDT
0.4060 +0.00 (+0.22%)
After hours: 07:59PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Cash flows from operating activities
Net Income
-190,929
-205,192
-142,309
-80,033
-125,712
Depreciation & amortization
1,093
1,023
302
263
262
Stock based compensation
6,501
8,898
12,697
8,579
17,842
Change in working capital
9,573
10,578
-15,227
-12,673
3,058
Accounts receivable
-1,502
-5,382
-1,067
-
-
Inventory
2,410
-21
-6,010
-
-
Accounts Payable
8,378
-4
4,126
-2,931
3,799
Other working capital
-135,177
-149,606
-107,083
-55,261
-56,507
Other non-cash items
3,505
4,069
2,940
642
-
Net cash provided by operating activites
-133,128
-146,667
-104,829
-55,097
-56,500
Cash flows from investing activities
Investments in property, plant and equipment
-2,049
-2,939
-2,254
-164
-7
Purchases of investments
-
-
0
-8,233
-
Sales/Maturities of investments
-
0
8,233
-
-
Net cash used for investing activites
-2,049
-2,689
6,229
-8,115
2,143
Cash flows from financing activities
Debt repayment
-
-
0
-4,010
-
Common stock issued
58,964
81,534
107,519
78,360
57,542
Dividends Paid
-
-
-
0
-157
Other financing activites
-1,604
-1,297
-3,742
-2,852
-3,010
Net cash used privided by (used for) financing activities
77,816
90,693
154,226
78,076
54,417
Net change in cash
-57,361
-58,663
55,626
14,864
60
Cash at beginning of period
65,093
72,251
16,625
1,761
1,701
Cash at end of period
7,732
13,588
72,251
16,625
1,761
Free Cash Flow
Operating Cash Flow
-133,128
-146,667
-104,829
-55,097
-56,500
Capital Expenditure
-2,049
-2,939
-2,254
-164
-7
Free Cash Flow
-135,177
-149,606
-107,083
-55,261
-56,507